• 1. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 2. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
• 3. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 4. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 5. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazoles

Comprehensive Overview of N-[(1-ethenyl-1H-pyrazol-4-yl)methyl]hydroxylamine (CAS No. 1695978-27-8)

N-[(1-ethenyl-1H-pyrazol-4-yl)methyl]hydroxylamine (CAS No. 1695978-27-8) is a specialized organic compound that has garnered significant attention in recent years due to its unique chemical structure and potential applications in pharmaceuticals, agrochemicals, and material science. The compound features a pyrazole ring, a hydroxylamine functional group, and an ethenyl substituent, making it a versatile intermediate for synthetic chemistry. Researchers and industry professionals are increasingly exploring its role in drug discovery, particularly in the development of novel small-molecule inhibitors and bioconjugation techniques.

One of the most frequently asked questions about N-[(1-ethenyl-1H-pyrazol-4-yl)methyl]hydroxylamine is its synthetic route and reactivity. The compound can be synthesized through multi-step organic reactions, often involving the condensation of 1H-pyrazole-4-carbaldehyde with hydroxylamine derivatives, followed by functionalization of the ethenyl group. Its reactivity is influenced by the presence of both nucleophilic (hydroxylamine) and electrophilic (ethenyl) moieties, enabling diverse transformations such as oxime formation, Michael additions, and polymerization reactions. These properties make it a valuable building block for designing bioactive molecules and functional materials.

In the context of current trends, N-[(1-ethenyl-1H-pyrazol-4-yl)methyl]hydroxylamine aligns with the growing demand for sustainable chemistry and green synthesis. Researchers are investigating eco-friendly catalytic systems to optimize its production, minimizing waste and energy consumption. Additionally, its potential applications in click chemistry and biocompatible polymers have sparked interest in fields like drug delivery and tissue engineering. These advancements are often highlighted in scientific literature and patent filings, reflecting its commercial and academic relevance.

Another area of interest is the spectroscopic characterization of N-[(1-ethenyl-1H-pyrazol-4-yl)methyl]hydroxylamine. Techniques such as NMR, IR spectroscopy, and mass spectrometry are routinely employed to confirm its structure and purity. The compound's stability under various conditions (e.g., pH, temperature) is also a critical factor for its storage and handling, often discussed in technical datasheets and safety guidelines. These details are essential for laboratories and manufacturers aiming to incorporate it into their workflows.

From a commercial perspective, N-[(1-ethenyl-1H-pyrazol-4-yl)methyl]hydroxylamine is available through specialized chemical suppliers and custom synthesis providers. Its pricing and availability may vary depending on the scale of procurement and purity requirements. Companies engaged in high-throughput screening or medicinal chemistry often seek this compound for its role in structure-activity relationship (SAR) studies. Furthermore, its inclusion in combinatorial libraries underscores its utility in modern drug discovery pipelines.

Looking ahead, the future of N-[(1-ethenyl-1H-pyrazol-4-yl)methyl]hydroxylamine appears promising, with ongoing research exploring its catalytic applications and biomedical potential. As the scientific community continues to uncover its properties, this compound is likely to play a pivotal role in advancing precision medicine and smart materials. For those interested in its latest developments, monitoring peer-reviewed journals and industry conferences is highly recommended.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)